Click Guardian v2 Tracking Pixel
Appointment

Dr Arif Al Nooryani

Consultant Cardiology

Book An Appointment
Locations
CMC Hospital – DHCC 2
Languages
English Arabic Urdu German

Bio

Dr Arif has been the CEO of Al Qassimi Hospital Sharjah – UAE (Since 2009), Head of Cardiac Cath Lab at Al Qassimi Hospital Sharjah – UAE (since 2004) & Head of Cardiac Centre (since 2012). He is the Member of National Committee with the objective of reduction of Mortality from the cardiovascular disease on National Level, under the Emirates National vision 2021 (since May 2016). He is also the Associate Professor of Cardiology at University of Sharjah (since Sept 2018), PhD studies in Cardiovascular Medicine, Medical faculty, University of Belgrade, Serbia (since 2018)

Dr. Arif is a member of the Emirates Cardiac Society – Head of the Interventional Cardiology (since March 2016), Emirates Medical Association & Royal College of Physicians & Surgeons of Glasgow since 2013. He was the National Coordinator for UAE – European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Dr. Arif is an official reviewer in International Journals such as Catheterization and Cardiovascular Interventions, Ex Reviewer – Elsevier Journals & Editorial board member for journal Cardiology Cases and Systematic Reviews (CCSR). Dr.Arif is fluent in Arabic, English, German and Urdu.

Treatments
  • Interventional Cardiology with Management of CTO’s & Complex PCI’s
  • Coronary imaging
  • Reperfusion therapy strategies
  • Innovative Technologies in CVD
  • BRS Implantation
  • Structural Heart Disease (TAVI & Mitral Clip)
  • LAA Occluders
  • Robotically Assisted PCI’s (Corindus)
  • Pathophysiology of acute coronary syndromes
Education
  • B.B.S. from the College of Medicine and Medical Sciences), ULM-Germany
  • German Board of Internal Medicine Certification
  • German Board Cardiology Certification
Publications
  • Arif A. Al Nooryani1 , Nagwa A. Abdelrahman1,2*, Hatem A. Helmy2 , Yehia T. Kishk2 and Ayman K. M. Hassan2 The role of optical coherence tomography guidance in scaffold versus stent optimization The Egyptian Heart Journal (2020) 72:77 https://doi.org/10.1186/s43044-020-00110-Z
  • Al-Nooryani A, Aboushokka W, Mehmedbegovic Z, Beleslin B. A case of mild-tointermediate left-main lesion with high-risk plaque features: “Blindness of physiology” for PCI guidance?. Clin Case Rep. 2020;00:1–5 https://doi.org/10.1002/ccr3.3197
  • Arif Al-Nooryani1*, Wael Aboushokka1 , Zlatko Mehmedbegovic2,3, Branko Beleslin 2,3 Very late coronary thrombosis following bioresorobable vascular scaffold implantation for spontaneous coronary artery dissection Interventional-Cardiology.1000644 © 2020 ISSN 1755-5302 Interventional Cardiology Case Report Interv. Cardiol. (2020) 12(1), 13-16
  • Al Nooryani A, Elabbassi WN, AlBaba B, Jalal JA, Abudaqa LM, Bhatia A, Abdelrahman NA, Boskovic N, Beleslin B. Long-term outcome of first 300 implanted Absorb bioresorbable vascular in an all-comers Middle East population. J Int Med Researsh 2018; in press. DOI: 10.1177/0300060518798994
  • Al Nooryani A, Abdalla GA, Ghafar TA, Bhatia A, Beleslin B. Implantation of bioresorbable vascular scaffold for the treatment of pudendal artery stenosis and erectile deysfunction. Andrologia 2018; in press. DOI: 10.1111/and.13153
  • Nooryani A, Elabbassi W, Markovic M, Dobric M, Beleslin B. Robotic-Assisted complete functional myocardial revascularization using bioresorbable bascular scaffolds. J Intervent Cardiology 2015;1:5
  • Darren Mylotte, MD,a Arnaud Sudre, MD,b Emmanuel Teiger, MD, PHD,c Jean François Obadia, MD, PHD,d Marcus Lee, MD, Mark Spence, MD,e Hazem Khamis, MD,f Arif Al Nooryani, MD,g Cedric Delhaye, MD,b Gilles Amr, MD,b Mohamad Koussa, MD,b Nicolas Debry, MD,b Nicolo Piazza, MD, PHD,h Thomas Modine, MD, PHDb Transcarotid Transcatheter Aortic Valve Replacement VOL. 9, NO. 5, 20 1 6 by the American College of Cardiology Foundation Issue SN 1 9 3 6 – 8 7 9 8
  • Elabbassia W, Al Ailaa F, Chowdhuryb MA, Najiba A, Zaidc H, Michelinc M, Al Nooryani A. The impact of severity of initial illness, determined by SOFA score, and presence of anemia on outcomes among patients requiring Extra Corporal Membrane Oxygenation (ECMO) support: A single center experience: Indian Heart J 2017; 69:762-766.
  • Abudaqa L, Hayder A, Al Nooryani A, Elabbassi W. Acute inferior myocardial Infarction in a young female: Initial presentation of Takayasu arteritis. 2016:
    DOI: 10.4172/2329-9495.1000180 ResearchGate
  • Elabbassi W, Al Nooryani Skirt followed by trouser stenting technique: True anatomical preservation of coronary Y-shaped bifurcation lesions while using“vanishing” bioresorbable scaffolds: A report of two cases: Cardiovascular Revascularization Medicine 18 (2017) 281–286.
  • Elabbassi W, Osman AN, Chowdhury MA, Al Nooryani A. Device-related thrombus overlying a left-atrial occlusion device implanted for persistent spontaneous echo contrast despite prolonged oral anticoagulation therapy. Cardiology 2013;125(2):78-81.
  • Abizaid A, Costa JR Jr, Banning A, Bartorelli AL, Dzavik V, Ellis S, Gao R, Holmes DR Jr, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Orlick A, Spaulding C, Worthley S, Urban PM; e-SELECT Investigators. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. JACC Cardiovasc Interv 2012;5(1):64-71
  • Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Džavík V, Ellis S, Gao R, Holmes D, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Worthley S; e-SELECT Investigators. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance)registry. J Am CollCardiol. 2011;57(13):1445-54

Related services

Start chat
1
Chat with us
Hello
I’d like to book an appointment